RespiCell<sup>TM</sup>: An Innovative Dissolution Apparatus for Inhaled Products

To overcome some of the shortfalls of the types of dissolution testing currently used for pulmonary products, a new custom-built dissolution apparatus has been developed. For inhalation products, the main in vitro characterisation required by pharmacopoeias is the deposition of the active pharmaceut...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Fabio Sonvico, Veronica Chierici, Giada Varacca, Eride Quarta, Davide D’Angelo, Ben Forbes, Francesca Buttini
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-09-01
Sarja:Pharmaceutics
Aiheet:
Linkit:https://www.mdpi.com/1999-4923/13/10/1541